Purdue Pharma Pleads Guilty to Criminal Charges

Purdue Pharma pleaded guilty to criminal charges over the handling of its prescription painkiller OxyContin on Tuesday afternoon, capping a deal with federal prosecutors to resolve a probe into the company’s role in the US opioid crisis.

Purdue Pharma pleaded guilty to criminal charges over the handling of its prescription painkiller OxyContin on Tuesday afternoon, capping a deal with federal prosecutors to resolve a probe into the company’s role in the US opioid crisis.

During a court hearing conducted remotely before US District Judge Madeline Cox Arleo in New Jersey, the OxyContin maker pleaded guilty to three felonies covering widespread misconduct.

The criminal violations included conspiring to defraud American officials and pay illegal kickbacks to doctors and an electronic health-care records vendor, all to help keep medically dubious opioid prescriptions flowing.

Purdue Chairman Steve Miller entered the guilty plea on the company’s behalf and admitted to its criminal conduct under questioning from Assistant US Attorney J. Stephen Ferketic. 

Of the three criminal counts against the company, two were for violations of a federal anti-kickback law while another charged the Stamford, Connecticut-based firm with defrauding the United States and violating the Food, Drug and Cosmetic Act.

 


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.